Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 2
1981 2
1982 1
1983 7
1984 8
1985 10
1986 3
1987 6
1988 7
1989 5
1990 4
1991 4
1992 6
1993 6
1994 4
1995 5
1996 6
1997 6
1998 3
1999 6
2000 5
2001 2
2002 9
2003 6
2004 7
2005 6
2006 8
2007 10
2008 11
2009 11
2010 13
2011 8
2012 9
2013 10
2014 8
2015 8
2016 6
2017 4
2018 4
2019 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Results by year

Filters applied: . Clear all
Page 1
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.
Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating M, Montserrat E, Chiorazzi N, Stilgenbauer S, Rai KR, Byrd JC, Eichhorst B, O'Brien S, Robak T, Seymour JF, Kipps TJ. Hallek M, et al. Among authors: caligaris cappio f. Blood. 2018 Jun 21;131(25):2745-2760. doi: 10.1182/blood-2017-09-806398. Epub 2018 Mar 14. Blood. 2018. PMID: 29540348 Free article.
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ; International Workshop on Chronic Lymphocytic Leukemia. Hallek M, et al. Among authors: caligaris cappio f. Blood. 2008 Jun 15;111(12):5446-56. doi: 10.1182/blood-2007-06-093906. Epub 2008 Jan 23. Blood. 2008. PMID: 18216293 Free PMC article.
Immunotherapy in lymphoma.
Ansell SM, Caligaris-Cappio F, Maloney DG. Ansell SM, et al. Among authors: caligaris cappio f. Hematol Oncol. 2017 Jun;35 Suppl 1:88-91. doi: 10.1002/hon.2408. Hematol Oncol. 2017. PMID: 28591421 Review. No abstract available.
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Devereux S, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Pocock C, Thornton P, Caligaris-Cappio F, Robak T, Delgado J, Schuster SJ, Montillo M, Schuh A, de Vos S, Gill D, Bloor A, Dearden C, Moreno C, Jones JJ, Chu AD, Fardis M, McGreivy J, Clow F, James DF, Hillmen P; RESONATE Investigators. Byrd JC, et al. Among authors: caligaris cappio f. N Engl J Med. 2014 Jul 17;371(3):213-23. doi: 10.1056/NEJMoa1400376. Epub 2014 May 31. N Engl J Med. 2014. PMID: 24881631 Free PMC article. Clinical Trial.
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.
Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J, Hensel M, Hopfinger G, Hess G, von Grünhagen U, Bergmann M, Catalano J, Zinzani PL, Caligaris-Cappio F, Seymour JF, Berrebi A, Jäger U, Cazin B, Trneny M, Westermann A, Wendtner CM, Eichhorst BF, Staib P, Bühler A, Winkler D, Zenz T, Böttcher S, Ritgen M, Mendila M, Kneba M, Döhner H, Stilgenbauer S; International Group of Investigators; German Chronic Lymphocytic Leukaemia Study Group. Hallek M, et al. Among authors: caligaris cappio f. Lancet. 2010 Oct 2;376(9747):1164-74. doi: 10.1016/S0140-6736(10)61381-5. Lancet. 2010. PMID: 20888994 Clinical Trial.
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.
Ferreri AJ, Reni M, Foppoli M, Martelli M, Pangalis GA, Frezzato M, Cabras MG, Fabbri A, Corazzelli G, Ilariucci F, Rossi G, Soffietti R, Stelitano C, Vallisa D, Zaja F, Zoppegno L, Aondio GM, Avvisati G, Balzarotti M, Brandes AA, Fajardo J, Gomez H, Guarini A, Pinotti G, Rigacci L, Uhlmann C, Picozzi P, Vezzulli P, Ponzoni M, Zucca E, Caligaris-Cappio F, Cavalli F; International Extranodal Lymphoma Study Group (IELSG). Ferreri AJ, et al. Among authors: caligaris cappio f. Lancet. 2009 Oct 31;374(9700):1512-20. doi: 10.1016/S0140-6736(09)61416-1. Epub 2009 Sep 18. Lancet. 2009. PMID: 19767089 Free article. Clinical Trial.
Chronic lymphocytic leukemia.
Ghia P, Ferreri AM, Caligaris-Cappio F. Ghia P, et al. Among authors: caligaris cappio f. Crit Rev Oncol Hematol. 2007 Dec;64(3):234-46. doi: 10.1016/j.critrevonc.2007.04.008. Epub 2007 Jun 1. Crit Rev Oncol Hematol. 2007. PMID: 17544290 Review.
Directing CLL-cell traffic.
Caligaris-Cappio F. Caligaris-Cappio F. Blood. 2015 Sep 10;126(11):1267-8. doi: 10.1182/blood-2015-07-657890. Blood. 2015. PMID: 26359431 Free article. No abstract available.
What is the CLL B-lymphocyte?
Dighiero G, Kipps T, Schroeder HW, Chiorazzi N, Stevenson F, Silberstein LE, Caligaris-Cappio F, Ferrarini M. Dighiero G, et al. Among authors: caligaris cappio f. Leuk Lymphoma. 1996 Oct;22 Suppl 2:13-39. doi: 10.3109/10428199609102700. Leuk Lymphoma. 1996. PMID: 9021706 Review. No abstract available.
Where is the biology of CLL leading us?
Caligaris-Cappio F, Chiorazzi N. Caligaris-Cappio F, et al. Semin Cancer Biol. 2010 Dec;20(6):361-2. doi: 10.1016/j.semcancer.2010.11.001. Semin Cancer Biol. 2010. PMID: 21130365 No abstract available.
229 results